| __timestamp | Arrowhead Pharmaceuticals, Inc. | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 24419536 | 2917513 |
| Thursday, January 1, 2015 | 34718089 | 7878291 |
| Friday, January 1, 2016 | 40998209 | 8366794 |
| Sunday, January 1, 2017 | 32022880 | 6610381 |
| Monday, January 1, 2018 | 19110051 | 6556000 |
| Tuesday, January 1, 2019 | 26556257 | 6930000 |
| Wednesday, January 1, 2020 | 52275890 | 8758000 |
| Friday, January 1, 2021 | 80981000 | 10806000 |
| Saturday, January 1, 2022 | 124431000 | 9844000 |
| Sunday, January 1, 2023 | 90932000 | 13481000 |
| Monday, January 1, 2024 | 98761000 |
Infusing magic into the data realm
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Arrowhead Pharmaceuticals, Inc. and Soleno Therapeutics, Inc. offer a fascinating study in contrasts. Over the past decade, Arrowhead's SG&A expenses have surged by approximately 300%, peaking in 2022. This reflects their aggressive expansion and investment in administrative capabilities. In contrast, Soleno Therapeutics has maintained a more stable SG&A trajectory, with expenses increasing by about 360% from 2014 to 2023. Notably, Soleno's expenses are consistently lower, suggesting a leaner operational model. However, the absence of data for Soleno in 2024 leaves room for speculation. As these companies navigate the biotech landscape, their differing approaches to SG&A optimization highlight the strategic choices that can define success.
Breaking Down SG&A Expenses: Novo Nordisk A/S vs Soleno Therapeutics, Inc.
Selling, General, and Administrative Costs: AbbVie Inc. vs Soleno Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Amgen Inc. and Soleno Therapeutics, Inc.
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Soleno Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Catalent, Inc. and Soleno Therapeutics, Inc.
Comparing SG&A Expenses: Blueprint Medicines Corporation vs Soleno Therapeutics, Inc. Trends and Insights
Comparing SG&A Expenses: Alkermes plc vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Apellis Pharmaceuticals, Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Bausch Health Companies Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Amicus Therapeutics, Inc. and Soleno Therapeutics, Inc.: SG&A Spending Patterns Compared
Arrowhead Pharmaceuticals, Inc. and Geron Corporation: SG&A Spending Patterns Compared
Arrowhead Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.: SG&A Expense Trends